Q3 2024 Holdings
Filed 2024-11-14 | 71 holdings | $3.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $55.4M | 15,272,172 | 1.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $58.7M | 1,000,000 | 1.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $66.9M | 5,972,257 | 2.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $77.0M | 857,219 | 2.4% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $78.4M | 3,018,935 | 2.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $80.3M | 3,548,001 | 2.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $85.3M | 3,750,945 | 2.7% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $86.9M | 3,868,104 | 2.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $88.1M | 2,200,000 | 2.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $91.5M | 3,180,025 | 2.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $98.0M | 3,500,000 | 3.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $101.7M | 4,950,000 | 3.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $110.7M | 12,721,460 | 3.5% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $117.1M | 1,600,693 | 3.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $117.9M | 3,282,000 | 3.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $123.2M | 3,843,900 | 3.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $123.9M | 4,347,464 | 3.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $126.9M | 4,400,654 | 4.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $137.7M | 6,000,560 | 4.4% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $139.5M | 12,526,486 | 4.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $197.9M | 365,000 | 6.3% |